CARMUSTINE 100mg powder + solvent infusion solution medication leaflet

L01AD01 • carmustine • Antineoplastic and immunomodulating agents | Alkylating agents | Nitrosoureas

Carmustine is a chemotherapy medication used to treat certain types of cancer, including lymphomas, multiple myeloma, and brain tumors. It belongs to the class of alkylating agents and works by interfering with the DNA of cancer cells, inhibiting their division and growth.

Carmustine is administered intravenously or as implants in the case of brain tumors. Treatment is usually given in cycles, and the dosage is adjusted based on the patient's weight, overall health, and the type of cancer being treated.

Patients need to be closely monitored during treatment to detect potential side effects, such as pulmonary toxicity, decreased blood cell counts, or liver function impairment. It is important to strictly follow the doctor's instructions.

Common side effects include nausea, vomiting, fatigue, and an increased risk of infections. In rare cases, more severe complications such as pulmonary fibrosis or liver failure may occur. Patients should inform their doctor of any unusual symptoms.